British bio-pharmaceutical company Shire has begun the countdown of entry into Korea, so there is much attention towards the future of the Shire
British bio-pharmaceutical company Shire has begun the countdown of entry into Korea, so there is much attention towards the future of the Shire.
The biggest change due to Shire's entry is expected to be in the ADHD (attention deficit hyperactivity disorder) drug market. Shire is holding the mar...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
